Objectives of Programme's Learning Outcomes

Learning Outcomes of UE

This lecture aims to provide deep understanding of biological drugs (medicines coming from biotechnologies), that are currently available on the market. Drugs will be studied according to pharmacotherapeutic categories and production processes.    

UE Content: description and pedagogical relevance

The first part of the lecture is dedicated to a general overview of  biologicals drugs (BD) : nature (proteins, nucleic acids, stem cells, ..), preparation, characterization, production and quality control.  Special emphasis will be given to analytical methods and biotechnologies used to study BD.
Second part of the lecture will focuse on the description of the different BD that are currently used in pharmacotherapy focusing on their target(s) in the human body.
Overview will include the following BD categories: antitumorals, immunomodulators, hormonal peptides, BD of cardiovascular system, antivirals, antiangiogenesis and vaccines.
For each BD, the mechanism of action, clinical use and adverse effects will be described.    

Prior Experience

Not applicable